Highly specialised interventions in visceral surgery

We treat this special type of cancer predominantly minimally invasive in order to reduce the risk of the operation for our patients with comparable radicality. The operation is often embedded in chemo- or radio-chemotherapy. Our clinic has actively contributed to the current guideline for the treatment of oesophageal cancer in Germany.

We treat pancreatic cancer in high numbers that significantly exceed the minimum quantity, with a low complication rate. We perform some of the pancreatic removals in a minimally invasive manner, while maintaining a comparable radicality.

Today, the occurrence of liver metastases can be treated or operated on in many tumour diseases, especially in the case of colon and rectum cancer, with a significant improvement in the prognosis. It is important that the assessment of whether the metastases can be removed is carried out by a surgeon experienced in liver surgery. We are one of the leading clinics for the removal of liver metastases or primary liver tumours and are often consulted by other hospitals on the question of whether metastases are removable.

Today, peritoneal carcinomatosis or peritoneal cancer is almost always diagnosed as a complex course of a cancer disease. Especially in recent years, considerable improvements in the treatment of peritoneal carcinomatosis have been achieved, mainly through the use of so-called cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC).

First, all visible tumour nodes are removed from the abdominal cavity with a correspondingly complex operation and the abdominal cavity is then rinsed under anaesthetic with chemotherapy. Suitable tumours for this treatment are metastases of colon and rectum cancer, malignant neoplasms of the appendix (e.g. mucinous appendix carcinoma), diseases of the peritoneum itself (e.g. pseudomyxomeric peritonitis). For other tumours, for example stomach cancer, this method is only used in selected situations.

Not all patients with peritoneal metastasis or the above mentioned tumor types get a survival advantage by using peritonectomy and HIPEC. It is important to identify all suitable patients. This requires particular experience and specialization of the treatment team and includes complex diagnostic procedures such as CT, MRI and PET examinations and also diagnostic laparoscopies in the decision-making process. The decision to undergo HIPEC therefore always depends on the type of tumour, the extent of the infestation, the patient's wishes and the surgeon's experience with the success of an operation in the particular situation. Our therapy recommendations are always made on an interdisciplinary basis in the Tumour Board.